Dei BioPharma is at the forefront of revolutionizing African healthcare by pioneering biotech and pharmaceutical advancements. With a cutting-edge facility and a commitment to innovation, we aim to make high-quality medicines and vaccines accessible across the continent and beyond.
Dei Biopharma specializes in developing and manufacturing innovative medicines and vaccines. It was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President).
While we are breaking ground as the first African biopharma company to enter Europe, the USA, and other developed markets, we remain committed to creating an impact in Africa and Uganda by creating jobs, pushing for sustainability, boosting healthcare access with affordable medicines, and growing talent through education and training programs.
This plant meets the world standards, at least the first bits that I have seen…. Local production is one of the ways of solving the problem of fake drugs so that the population consumes the right medicine.
Dei Biopharma Ltd is different from other foreign biotechnology companies such as Moderna that are being hosted by African countries.
Our leadership team combines decades of pharmaceuticals, biotechnology, and global healthcare expertise. Together, they lead DEI BioPharma in its mission to redefine healthcare for the better
Managing Director
Executive Director
Dei Biopharma is always open to collaborations, partnerships, and inquiries. Whether you’re a healthcare provider, researcher, or global partner, we’d love to hear from you.
KAMPALA, Uganda — Dei BioPharma, a global biotechnology company focused on affordable, next-generation medicines, today announced the development of a CRISPR-based gene...
Kampala — Ugandan pharmaceutical manufacturer Dei Biopharma led by scientist Dr. Matthias Magoola has received a significant boost in its...
KAMULI, Uganda — President Museveni on Thursday November 20, launched the Dei Biopharma Advanced Agro-Processing and Biotech Park in Namasagali,...
